<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="08/06/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9348104" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9348104</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="T1" lex="helenalin">Helenalin</term>, an <term sem="Organic_compound_other" id="T2" lex="anti-inflammatory_sesquiterpene_lactone">anti-inflammatory sesquiterpene lactone</term> from <term sem="Multicellular_organism_natural" id="T3" lex="Arnica">Arnica</term>, selectively inhibits <term sem="Protein_family_or_group" id="T4" lex="transcription_factor">transcription factor</term> <term sem="Protein_complex" id="T5" lex="NF-kappaB">NF-kappaB</term> [see comments]</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="T5" />
<cause idref="T1" />
<clue>Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively <clueType>inhibits</clueType> transcription factor NF-kappaB [see comments]</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Organic_compound_other" id="A1"><term sem="Organic_compound_other" id="T6" lex="alcoholic_extract">Alcoholic extracts</term> prepared form <term sem="Multicellular_organism_natural" id="T7" lex="Arnicae_flos">Arnicae flos</term></term>, the collective name for <term sem="Body_region" id="T8" lex="flowerhead">flowerheads</term> from <term sem="Multicellular_organism_natural" id="T9" lex="Arnica_montana">Arnica montana</term> and <term sem="Body_region" id="T10" lex="A._chamissonis">A. chamissonis</term> ssp. foliosa, are used therapeutically as <term sem="Other" id="T11" lex="anti-inflammatory_remedy">anti-inflammatory remedies</term>.</sentence>
<event id="E2">
<type class="Negative_regulation" />
<cause idref="A1" />
<clue>Alcoholic extracts prepared form Arnicae flos, the collective name for flowerheads from Arnica montana and A. chamissonis ssp. foliosa, are used therapeutically as <clueType>anti-inflammatory</clueType> remedies.</clue>
<comment>TPS: A1</comment>
</event>
<sentence id="S3">The active ingredients mediating the <term sem="Other" id="T12" lex="pharmacological_effect">pharmacological effect</term> are mainly <term sem="Organic_compound_other" id="T13" lex="sesquiterpene_lactone">sesquiterpene lactones</term>, such as <term sem="Organic_compound_other" id="T14" lex="helenalin">helenalin</term>, <term sem="Organic_compound_other" id="T15" lex="11alpha,13-dihydrohelenalin">11alpha,13-dihydrohelenalin</term>, <term sem="Organic_compound_other" id="T16" lex="chamissonolid">chamissonolid</term> and their <term sem="Organic_compound_other" id="T17" lex="ester_derivative">ester derivatives</term>.</sentence>
<event id="E3">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T14" />
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T15" />
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T16" />
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T17" />
<clue>The active ingredients <clueType>mediating</clueType> the pharmacological effect are mainly <corefCause>sesquiterpene lactones</corefCause>, such as helenalin, 11alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives.</clue>
</event>
<sentence id="S4">While these compounds affect various <term sem="Other" id="T18" lex="cellular_process">cellular processes</term>, current data do not fully explain how <term sem="Organic_compound_other" id="T19" lex="sesquiterpene_lactone">sesquiterpene lactones</term> exert their <term sem="Other" id="T20" lex="anti-inflammatory_effect">anti-inflammatory effect</term>.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="T18" />
<cause idref="T19" />
<clue>While <corefCause>these compounds</corefCause> <clueType>affect</clueType> various cellular processes, current data do not fully explain how sesquiterpene lactones exert their anti-inflammatory effect.</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Regulation" />
<cause idref="T19" />
<clue>While these compounds affect various cellular processes, current data do not fully explain how sesquiterpene lactones <clueType>exert</clueType> <corefCause>their</corefCause> <clueType>anti-inflammatory effect</clueType>.</clue>
<comment>NO THEME</comment>
</event>
<sentence id="S5">We show here that <term sem="Organic_compound_other" id="T21" lex="helenalin">helenalin</term>, and, to a much lesser degree, <term sem="Organic_compound_other" id="T22" lex="11alpha,13-dihydrohelenalin">11alpha,13-dihydrohelenalin</term> and <term sem="Organic_compound_other" id="T23" lex="chamissonolid">chamissonolid</term>, inhibit activation of <term sem="Protein_family_or_group" id="T24" lex="transcription_factor">transcription factor</term> <term sem="Protein_complex" id="T25" lex="NF-kappaB">NF-kappaB</term>.</sentence>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="T21" />
<clue>We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="T22" />
<clue>We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E12" />
<cause idref="T23" />
<clue>We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, <clueType>inhibit</clueType> activation of transcription factor NF-kappaB.</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T25" />
<clue>We show here that helenalin, and, to a much lesser degree, 11alpha,13-dihydrohelenalin and chamissonolid, inhibit <clueType>activation</clueType> <linkTheme>of</linkTheme> transcription factor NF-kappaB.</clue>
</event>
<sentence id="S6">This difference in efficacy, which correlates with the compounds&apos; <term sem="Other" id="T26" lex="anti-inflammatory_potency">anti-inflammatory potency</term> in vivo, may be explained by differences in structure and conformation.</sentence>
<sentence id="S7"><term sem="Protein_complex" id="T27" lex="NF-kappaB">NF-kappaB</term>, which resides in an inactive, <term sem="Protein_complex" id="T28" lex="cytoplasmic_complex">cytoplasmic complex</term> in <term sem="Cell_cultured" id="T29" lex="unstimulated_cell">unstimulated cells</term>, is activated by <term sem="Other" id="T30" lex="phosphorylation">phosphorylation</term> and <term sem="Other" id="T31" lex="degradation">degradation</term> of its <term sem="Protein_molecule" id="T32" lex="inhibitory_subunit">inhibitory subunit</term>, <term sem="Protein_molecule" id="T33" lex="IkappaB">IkappaB</term>.</sentence>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="T27" />
<cause idref="E16" />
<clue>NF-kappaB, which resides in an inactive, <clueLoc>cytoplasmic</clueLoc> complex in unstimulated cells, is <clueType>activated</clueType> <linkCause>by</linkCause> phosphorylation and degradation of its inhibitory subunit, IkappaB.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T27" />
<cause idref="E17" />
<clue>NF-kappaB, which resides in an inactive, <clueLoc>cytoplasmic</clueLoc> complex in unstimulated cells, is <clueType>activated</clueType> <linkCause>by</linkCause> phosphorylation and degradation of its inhibitory subunit, IkappaB.</clue>
</event>
<event id="E16">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T33" />
<clue>NF-kappaB, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by <clueType>phosphorylation</clueType> and degradation <linkTheme>of</linkTheme> its inhibitory subunit, IkappaB.</clue>
</event>
<event id="E17">
<type class="Protein_catabolism" />
<theme idref="T33" />
<clue>NF-kappaB, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by phosphorylation and <clueType>degradation</clueType> <linkTheme>of</linkTheme> its inhibitory subunit, IkappaB.</clue>
</event>
<sentence id="S8"><term sem="Organic_compound_other" id="T34" lex="helenalin">Helenalin</term> inhibits <term sem="Other" id="T35" lex="NF-kappaB_activation"><term sem="Protein_complex" id="T36" lex="NF-kappaB">NF-kappaB</term> activation</term> in response to four different <term sem="Other" id="A2">stimuli</term> in <term sem="Cell_natural" id="T37" lex="T-cell">T-cells</term>, <term sem="Cell_natural" id="T38" lex="B-cell">B-cells</term> and <term sem="Cell_natural" id="T39" lex="epithelial_cell">epithelial cells</term> and abrogates <term sem="Protein_molecule" id="T41" lex="kappaB">kappaB</term>-driven <term sem="Other" id="A3">gene expression</term>.</sentence>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T34" />
<clue>Helenalin <clueType>inhibits</clueType> NF-kappaB activation in response to four different stimuli <clueLoc>in T-cells, B-cells and epithelial cells</clueLoc> and abrogates kappaB-driven gene expression.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="T36" />
<cause idref="A2" />
<clue>Helenalin inhibits NF-kappaB <clueType>activation</clueType> <linkCause>in response to</linkCause> four different stimuli <clueLoc>in T-cells, B-cells and epithelial cells</clueLoc> and abrogates kappaB-driven gene expression.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="T34" />
<clue>Helenalin inhibits NF-kappaB activation in response to four different stimuli in T-cells, B-cells and epithelial cells and <clueType>abrogates</clueType> kappaB-driven gene expression.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="A3" />
<cause idref="T41" />
<clue>Helenalin inhibits NF-kappaB activation in response to four different stimuli in T-cells, B-cells and epithelial cells and abrogates kappaB-<clueType>driven</clueType> gene expression.</clue>
</event>
<sentence id="S9">This inhibition is selective, as the activity of four other <term sem="Protein_family_or_group" id="T42" lex="transcription_factor">transcription factors</term>, <term sem="Protein_molecule" id="T43" lex="Oct-1">Oct-1</term>, <term sem="Protein_molecule" id="T44" lex="TBP">TBP</term>, <term sem="Protein_molecule" id="T45" lex="Sp1">Sp1</term> and <term sem="Protein_molecule" id="T46" lex="STAT_5">STAT 5</term> was not affected.</sentence>
<event assertion="non-exist" id="E26">
<type class="Regulation" />
<theme idref="T43" />
<cause idref="T34" />
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was not <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event assertion="non-exist" id="E27">
<type class="Regulation" />
<theme idref="T44" />
<cause idref="T34" />
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was not <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event assertion="non-exist" id="E28">
<type class="Regulation" />
<theme idref="T45" />
<cause idref="T34" />
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was not <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event assertion="non-exist" id="E29">
<type class="Regulation" />
<theme idref="T46" />
<cause idref="T34" />
<clue>This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Sp1 and STAT 5 was not <clueType>affected</clueType>.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<sentence id="S10">We show that inhibition is not due to a direct modification of the active <term sem="Protein_complex" id="T47" lex="NF-kappaB_heterodimer"><term sem="Protein_complex" id="T48" lex="NF-kappaB">NF-kappaB</term> heterodimer</term>.</sentence>
<event assertion="non-exist" id="E30">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="E31" />
<clue>We show that <corefTheme>inhibition</corefTheme> is not <clueType>due</clueType> <linkCause>to</linkCause> a direct modification of the active NF-kappaB heterodimer.</clue>
</event>
<event id="E31">
<type class="Regulation" />
<theme idref="T47" />
<clue>We show that inhibition is not due to a direct <clueType>modification</clueType> <linkTheme>of</linkTheme> the active NF-kappaB heterodimer.</clue>
</event>
<sentence id="S11">Rather, <term sem="Organic_compound_other" id="T49" lex="helenalin">helenalin</term> modifies the <term sem="Protein_complex" id="T50" lex="NF-kappaB/IkappaB_complex"><term sem="Protein_complex" id="A4">NF-kappaB</term>/<term sem="Protein_molecule" id="T51" lex="IkappaB">IkappaB</term> complex</term>, preventing the release of <term sem="Protein_molecule" id="T52" lex="IkappaB">IkappaB</term>.</sentence>
<event id="E32">
<type class="Regulation" />
<theme idref="T50" />
<cause idref="T49" />
<clue>Rather, helenalin <clueType>modifies</clueType> the NF-kappaB/IkappaB complex, preventing the release of IkappaB.</clue>
</event>
<event id="E34">
<type class="Localization" />
<theme idref="T52" />
<clue>Rather, helenalin modifies the NF-kappaB/IkappaB complex, preventing the <clueType>release</clueType> <linkTheme>of</linkTheme> IkappaB.</clue>
</event>
<event id="E35">
<type class="Negative_regulation" />
<theme idref="E34" />
<cause idref="E32" />
<clue>Rather, helenalin modifies the NF-kappaB/IkappaB complex, <clueType>preventing</clueType> the release of IkappaB.</clue>
</event>
<sentence id="S12">These data suggest a molecular mechanism for the <term sem="Other" id="T53" lex="anti-inflammatory_effect">anti-inflammatory effect</term> of <term sem="Organic_compound_other" id="T54" lex="sesquiterpene_lactone">sesquiterpene lactones</term>, which differs from that of other <term sem="Organic_compound_other" id="T55" lex="nonsteroidal_anti-inflammatory_drug">nonsteroidal anti-inflammatory drugs</term> (<term sem="Organic_compound_other" id="T56" lex="NSAID">NSAIDs</term>), <term sem="Organic_compound_other" id="T57" lex="indomethacin">indomethacin</term> and <term sem="Organic_compound_other" id="T58" lex="acetyl_salicylic_acid">acetyl salicylic acid</term>.</sentence>
<event id="E36">
<type class="Negative_regulation" />
<cause idref="T54" />
<clue>These data suggest a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> <linkCause>of</linkCause> sesquiterpene lactones, which differs from that of other nonsteroidal anti-inflammatory drugs (NSAIDs), indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment>
</event>
<event id="E39">
<type class="Negative_regulation" />
<cause idref="T57" />
<clue>These data suggest a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> of sesquiterpene lactones, which differs from that <linkCause>of</linkCause> <corefCause>other nonsteroidal anti-inflammatory drugs (NSAIDs)</corefCause>, indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment>
</event>
<event id="E40">
<type class="Negative_regulation" />
<cause idref="T58" />
<clue>These data suggest a molecular mechanism for the <clueType>anti-inflammatory effect</clueType> of sesquiterpene lactones, which differs from that <linkCause>of</linkCause> <corefCause>other nonsteroidal anti-inflammatory drugs (NSAIDs)</corefCause>, indomethacin and acetyl salicylic acid.</clue>
<comment>NO THEME</comment>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
